Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19 |
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection |
Hydroxychloroquine and azithromycin as a treatment of COVID-19 |
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc) |
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern? |
What is the role of rheumatologists in the era of COVID-19? |
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
Macrolide treatment for COVID-19: Will this be the way forward? |
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement |
Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection who have no comorbidities like diabetes mellitus: A structured summary of a study protocol for a randomized controlled trial |
Disclaimer: This content is made available only in academic interest.